Heat shock response reduces intestinal permeability in septic mice: potential role of interleukin-10.
Sepsis and other critical illnesses are associated with increased permeability of the intestinal mucosa. Loss of mucosal integrity may lead to multiple organ failure in these conditions. We tested the hypothesis that induction of the heat shock response reduces sepsis-induced increase in intestinal permeability. The heat shock response was induced in mice by intraperitoneal injection of 10 mg/kg sodium arsenite. Two hours later, at which time mucosal heat shock protein 72 levels were increased, sepsis was induced by cecal ligation and puncture (CLP) or sham operation was performed. Sixteen hours after sham operation or CLP, intestinal permeability was determined by measuring the appearance in blood of 4.4-kDa fluorescein isothiocyanate-conjugated dextran and 40-kDa horseradish peroxidase administered by gavage. Sepsis resulted in increased mucosal permeability for both markers, and this effect of sepsis was substantially reduced in mice treated with sodium arsenite. Plasma levels of the anti-inflammatory cytokine interleukin (IL)-10 were increased in septic mice pretreated with sodium arsenite, and the protective effect of sodium arsenite on intestinal permeability in septic mice was reversed by treatment with anti-IL-10 antibody. The present results suggest that sepsis-induced increase in mucosal permeability can be reduced by the heat shock response and that increased IL-10 levels may be involved in the protective effects of the heat shock response.
Wang
Quan
Q
Department of Surgery, University of Cincinnati, Cincinnati, Ohio 45267, USA.
Hasselgren
Per-Olof
PO
D000818:Animals; D018053:Arsenites / Q000494:pharmacology; D001424:Bacterial Infections / Q000150:complications / Q000378:metabolism*; D006358:Hot Temperature; D016753:Interleukin-10 / Q000502:physiology; D007413:Intestinal Mucosa / Q000378:metabolism*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010539:Permeability / Q000187:drug effects; D012769:Shock / Q000139:chemically induced / Q000150:complications / Q000378:metabolism*; D017670:Sodium Compounds / Q000494:pharmacology
D018053:Arsenites; D017670:Sodium Compounds; D016753:Interleukin-10; C017947:sodium arsenite